Global Phone +1-347-878-0992
1160 Fifth Avenue, Suite #112
New York, NY 10029
Contact Dr. Preter
Tag Archives: Medication effects – wanted and unwanted
Panic Attacks and Panic Disorder – what is it and how can it be treated? Continue reading
Dementia and Alzheimers’ Disease – How Can It Be Treated?
The Latin word “De-mentia”, literally means, the removal of a person from their own mind. It stands for a significant decrease in brain function, including memory, goal-directed thinking, orientation in space and time, and language ability.
Most dementias are progressive. They cannot be cured and will gradually cause more severe problems for the patient, and for the patient’s caretakers. As the population ages, Alzheimer’s disease is on its way to becoming the third most common fatal disease.
Prescription medications on the market starting in the 1990s to treat dementia have been a disappointment to patients and doctors alike.
The frustration caused by this situation prompted me to make the development of an anti-dementia treatment protocol a major focus of my clinical work.
As always, we start with a thorough neuropsychiatric assessment, looking for potentially reversible causes of cognitive decline such as a thyroid condition, vitamin deficiency, a sleep disorder, elevated blood sugar and diabetes. Importantly, untreated depression and chronic high stress and anxiety levels are associated with a higher risk for dementia. Most of the time, psychotherapy is a far better alternative to the all-too-common multiple prescription drugs.
The protocol uses a number of carefully evaluated novel interventions and components based on sound neuroscientific principles, sourced from both functional medicine and traditional medical systems, such as Ayurvedic and traditional Chinese medicine.
The protocol stabilizes many of my patients, and improves their functioning and quality of life. It has shown promising results not only for dementia, but also for traumatic brain injury. Continue reading
Update on the treatment of Alzheimer’s Disease – from the International Conference of Parkinson Disease & Movement Disorders/MDS Developing World Education Program (DWEP). Shanghai First People’s Hospital, Jiao Tong University, Shanghai, PRC. September 30, 2016
Update on the treatment of Alzheimer’s Disease – from the International Conference of Parkinson Disease & Movement Disorders/MDS Developing World Education Program (DWEP). Shanghai First People’s Hospital, Jiao Tong University, Shanghai, PRC. September 30, 2016 Continue reading
Overprescribing Anticholinergics May Hurt Recovery in Elderly http://news.psu.edu/story/389729/2016/01/28/research/anticholinergics-may-not-be-best-choice-rehab-patients-dementia UNIVERSITY PARK, Pa. — During rehabilitation following an acute hospital stay, medications that block neurotransmitters may be overprescribed to older patients suffering from delirium superimposed on dementia, according to health researchers. Specifically, strong anticholinergic medications may be prescribed to older adults when there are other suitable options. An anticholinergic medication blocks the neurotransmitter acetylcholine in the nervous system. These drugs are prescribed for a variety of symptoms, including incontinence, depression and insomnia. While their use can be … Continue reading
Serotonin and the marketing of a depression myth Serotonin and depression BMJ 2015; 350 doi: http://dx.doi.org.ezproxy.cul.columbia.edu/10.1136/bmj.h1771 (Published 21 April 2015)Cite this as: BMJ 2015;350:h1771 Article Related content Metrics Responses David Healy, professor of psychiatry Author affiliations firstname.lastname@example.org The marketing of a myth The serotonin reuptake inhibiting (SSRI) group of drugs came on stream in the late 1980s, nearly two decades after first being mooted. The delay centred on finding an indication. They did not have hoped for lucrative antihypertensive or antiobesity profiles. A 1960s idea that serotonin concentrations might be lowered … Continue reading